Kula Investments’s Vir Biotechnology VIR Stock Holding History

Kula Investments’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,486	Closed	-$341K	–	866
2022 Q4	$341K	Buy	+13,486	New	+$331K	0.1%	342

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Kula Investments's VIR Position: Q1 2023 in Review

Kula Investments sold out of Vir Biotechnology (VIR) in Q1 2023, closing a stake of 13,486 shares — an estimated $341K sold.

Kula Investments first reported a position in VIR in Q4 2022 and held it in 1 quarter. The position peaked at $341K in Q4 2022. 231 funds tracked by Wall St. Rank hold VIR as of Q1 2023.

Kula Investments reported no remaining Vir Biotechnology position as of Q1 2023 after selling out during the quarter.
Kula Investments sold 13,486 Vir Biotechnology shares in Q1 2023, an estimated $341K.
Kula Investments first reported a position in Vir Biotechnology in Q4 2022 and held it in 1 quarter.
Kula Investments's Vir Biotechnology position peaked at $341K in Q4 2022.
231 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.